Shared Decision Making in Paediatric Inflammatory Bowel Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2025

Conditions
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative ColitisIBD
Interventions
OTHER

Decision Coach Sessions

"Participants in the intervention group and their families will be referred to the DC to meet independently and discuss recommended treatment pathways.~Multiple sessions may be necessary until a final decision is reached. All SDM consults will be done virtually using a secure videoconferencing platform. The Ottawa Family Decision Guide will be used to facilitate the discussion. A DA will be provided to the study participants in the form of information cards containing information about different treatment options in pediatric IBD. This includes administration schedule, side effects, risk of cancer, among others. The DA has been developed and provided by the Cincinnati Children's Hospital Medical Center and adapted to the Canadian setting with electronic version by this research group with approval from the authors."

Sponsors
All Listed Sponsors
collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

London Health Sciences Centre

OTHER

NCT05689892 - Shared Decision Making in Paediatric Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter